B, K., A, T., V, D., E, C., S, S., & A, A. (2011). Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA). Current medical research and opinion, 27(2), 303. https://doi.org/10.1185/03007995.2010.542081
Chicago Style (17th ed.) CitationB, Karamanos, Thanopoulou A, Drossinos V, Charalampidou E, Sourmeli S, and Archimandritis A. "Study Comparing the Effect of Pioglitazone in Combination with Either Metformin or Sulphonylureas on Lipid Profile and Glycaemic Control in Patients with Type 2 Diabetes (ECLA)." Current Medical Research and Opinion 27, no. 2 (2011): 303. https://doi.org/10.1185/03007995.2010.542081.
MLA (9th ed.) CitationB, Karamanos, et al. "Study Comparing the Effect of Pioglitazone in Combination with Either Metformin or Sulphonylureas on Lipid Profile and Glycaemic Control in Patients with Type 2 Diabetes (ECLA)." Current Medical Research and Opinion, vol. 27, no. 2, 2011, p. 303, https://doi.org/10.1185/03007995.2010.542081.